Precision Medicine In Psychiatry: Astellas Joins Search For Biomarkers, Drug Targets
Executive Summary
Biomarkers for psychiatric disorders are lacking, but Astellas is investing in its own and external efforts to identify drug targets as well as patients who'll respond to new therapies.